Genetic Mosaicism in Calmodulinopathy
Authors:
- 1 September 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 12 (9) , 375-385
Abstract
Background: CaM (calmodulin) mutations are associated with congenital arrhythmia susceptibility (calmodulinopathy) and are most often de novo. In this report, we sought to broaden the genotype-phenotype spectrum of calmodulinopathies with 2 novel calmodulin mutations and to investigate mosaicism in 2 affected families. Methods: CaM mutations were identified in 4 independent cases by DNA sequencing. Biochemical and electrophysiological studies were performed to determine functional consequences of each mutation. Results: Genetic studies identified 2 novel CaM variants ( CALM3 -E141K in 2 cases; CALM1 -E141V) and one previously reported CaM pathogenic variant ( CALM3 -D130G) among 4 probands with shared clinical features of prolonged QTc interval (range 505–725 ms) and documented ventricular arrhythmia. A fatal outcome occurred for 2 of the cases. The parents of all probands were asymptomatic with normal QTc duration. However, 2 of the families had multiple affected offspring or multiple occurrences of intrauterine fetal demise. The mother from the family with recurrent intrauterine fetal demise exhibited the CALM3 -E141K mutant allele in 25% of next-generation sequencing reads indicating somatic mosaicism, whereas CALM3 -D130G was present in 6% of captured molecules of the paternal DNA sample, also indicating mosaicism. Two novel mutations (E141K and E141V) impaired Ca 2+ binding affinity to the C-domain of CaM. Human-induced pluripotent stem cell-derived cardiomyocytes overexpressing mutant or wild-type CaM showed that both mutants impaired Ca 2+ -dependent inactivation of L-type Ca 2+ channels and prolonged action potential duration. Conclusions: We report 2 families with somatic mosaicism associated with arrhythmogenic calmodulinopathy, and demonstrate dysregulation of L-type Ca 2+ channels by 2 novel CaM mutations affecting the same residue. Parental mosaicism should be suspected in families with unexplained fetal arrhythmia or fetal demise combined with a documented CaM mutation.Keywords
This publication has 35 references indexed in Scilit:
- Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compactionEP Europace, 2014
- Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variationGenome Research, 2013
- Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac DeathThe American Journal of Human Genetics, 2012
- A germ-line-selective advantage rather than an increased mutation rate can explain some unexpectedly common human disease mutationsProceedings of the National Academy of Sciences, 2008
- Severe arrhythmia disorder caused by cardiac L-type calcium channel mutationsProceedings of the National Academy of Sciences, 2005
- CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and AutismCell, 2004
- Stillbirths, Sudden Infant Deaths, and Long-QT SyndromeCirculation, 2004
- Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ LineScience, 2003
- Two-dimensional 1H Nuclear Magnetic Resonance Studies of the Half-saturated (Ca2+)1 State of Calbindin D9kJournal of Molecular Biology, 1993
- Localization of the Human Bona Fide Calmodulin Genes CALM1, CALM2, and CALM3 to Chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3Genomics, 1993